Evidence map›Paper›PMID 36419651›Full record

ArticleChild neurology open

Miyoshi Muscular Dystrophy Due to Novel Splice Site Variants in

Grace Bryant, Steven A Moore, James S Nix, Grace Rice, Murat Gokden, Aravindhan Veerapandiyan

Open access · hybridAbstract readCase Reports
In one paragraph

Article in Child neurology open. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 56% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Grace BryantDivision of Neurology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Steven A MooreDepartment of Pathology, University of Iowa Carver College of Medicine and Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Center, Iowa City, IA, USA.
James S NixDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Grace RiceDivision of Neurology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Murat GokdenDepartment of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Aravindhan VeerapandiyanDivision of Neurology, Department of Pediatrics, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA.ORCID https://orcid.org/0000-0002-3065-3956
Arkansas Children's Hospital · USUniversity of Arkansas for Medical Sciences · USUniversity of Iowa · US

Funding

Muscular Dystrophy Specialized Research Center: Project 2P50NS053672 · NINDS · UNIVERSITY OF IOWA · PI KEVIN P. CAMPBELL · 2020 to 2026
$11.9M
NINDS NIH HHS P50 NS053672
6 · The paper itself

Abstract

Dysferlinopathies are a group of phenotypically heterogeneous disorders caused by pathogenic variants in the

Indexed as

geneticsmyopathynext-generation sequencing

Identifiers

PMID36419651
PMCPMC9677140
OpenAlexW4310644923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.